Oxidative stress contributes to airway inflammation and exhaled hydrogen peroxide (H 2 O 2 ) and nitric oxide (NO) are elevated in asthmatic patients. We determined the concentrations of expired H 2 O 2 and NO in 116 asthmatic (72 stable steroid-naive, 30 stable steroid-treated, and 14 severe steroid-treated unstable patients) and in 35 healthy subjects, and studied the relation between exhaled 
Oxidative stress, defined as an increased exposure to oxidants and/or decreased antioxidant capacities, is implicated in airway inflammatory airway diseases, such as chronic obstructive pulmonary disease (COPD) and asthma (1) (2) (3) (4) . Inflammatory cells, especially eosinophils which produce more superoxide anions (O 2 и ) than neutrophils or macrophages, release several reactive oxygen-and nitrogen-derived species such as nitric oxide (NO). O 2 и and NO combine to form peroxynitrite (ONOO Ϫ ), which is highly reactive and may damage airway epithelium (5) (6) (7) (8) . NO has several biological activities in the airways and rapidly reacts to generate peroxynitrite anions (9, 10) . O 2 Ϫ is rapidly metabolized to form hydrogen peroxide (H 2 O 2 ), which diffuses into the airway lining fluid and may evaporate into exhaled air.
H 2 O 2 in exhaled breath condensate is increased in COPD, adult respiratory distress syndrome, cigarette smokers, and asthma (11) (12) (13) (14) (15) (16) , and may be used as a noninvasive marker of oxidative stress. However, the effect of corticosteroids on production of reactive oxygen species (ROS) or H 2 O 2 is not certain. Exhaled NO is another noninvasive marker of airway inflammation, but could be dose-dependently reduced following corticosteroid treatment (17) (18) (19) , and may be of limited value in assessment of asthmatic inflammation in patients with asthma treated with steroids. Therefore, we have evaluated the utility these two noninvasive markers of oxidative stress and airway inflammation in asthma of different severity and have compared them with the eosinophils in induced sputum and airway hyperresponsiveness.
METHODS

Subjects
Four groups of nonsmoking subjects were studied ( Table 1) . None of the 35 nonsmoking nonatopic normal subjects had a history of respiratory or cardiovascular disease or was receiving any long-term medication; 72 steroid-naive atopic asthmatic patients were receiving ␤ 2 -agonists only as required; 30 stable steroid-treated atopic asthmatic patients (without asthma symptoms for Ͼ 4 wk prior to study with no history of upper respiratory infection in the last month) were treated with inhaled corticosteroids; 14 steroid-treated patients (3 nonatopic) were unstable (peak flow variability Ͼ 20%, nocturnal wheezing and daily asthma symptoms) despite treatment with inhaled and oral steroids. Atopic status was assessed by positive skin prick tests ( Ͼ 3 mm). The protocol was approved by the ethics committee of the Royal Brompton Hospital, and informed consent from each subject was obtained.
Study Design
Subjects' details were obtained and then baseline spirometry and exhaled NO were measured, followed by collection of expired breath condensate. In some patients, this was followed by methacholine challenge and/or sputum induction.
Expired Breath Condensate and H 2 O 2 Measurement
Expired breath condensate was collected by using a glass condensing device, with an inner glass chamber which contained ice and was suspended in a larger chamber (Figure 1 ). Condensate was formed on the outside surface of the inside glass that was separated from ambient air. After rinsing their mouth, subjects breathed tidally through a mouthpiece connected to the inlet for 15 min while wearing a nose-clip. The mouthpiece was also used as a saliva trap. Approximately 1 ml of breath condensate was collected and stored at Ϫ 70 Њ C. H 2 O 2 was measured using a colorimetric assay as described previously (20) . Briefly, 100 l of condensate was mixed with 100 l of 420 M 3 Ј 3 Ј 5 Ј 5 Ј -tetramethylbenzidine in 0.42 M citrate buffer pH 3.8 and 10 l of horseradish peroxidase (52.5 U/ml). The samples were incubated at room temperature for 20 min and the reaction stopped by the addition of 10 l of 2 N sulfuric acid. The product was measured spectrophotometrically (Model AR 8003; Labtech Int. Ltd., Uckfield, UK) at 450 nm. A standard curve of H 2 O 2 was performed for each assay with a detection limit of 0.1 M. In 21 normal subjects the variation between the H 2 O 2 values on separate days was minor (7.6%).
Exhaled NO Measurements
Exhaled NO was measured by a chemiluminescence analyzer (Model LR2000; Logan Research, Rochester, UK) as previously described (21, 22) . The analyzer is sensitive to NO from 1 (ppb, by volume) to 5,000 ppb, and with a resolution of 0.3 ppb. In addition to NO, the analyzer also measures CO 2 (resolution 0.1% CO 2 ; response time, 200 ms) and sample pressure and volume in real time. The analyzer was calibrated using certified NO mixtures (90 ppb and 436 ppb) in nitrogen (BOC Special Gases, Guildford, UK). Measurements of exhaled NO were made by slow exhalation (5-6 L/min) from total lung capacity for 15 to 20 s against a mild resistance to exclude nasal contamination. The value corresponding to the plateau of the endexhaled CO 2 reading (5% CO 2 ) was taken as representative of an alveolar sample. In these measurements the pressure during expiration was kept constant (3 Ϯ 0.4 mm Hg) by using a visual display of expiratory flow measured by pressure and volume sensors in the analyzer.
Sputum Induction
Subjects (n ϭ 32) were instructed to wash their mouth thoroughly with water and then to inhale 3.5% saline nebulized via an ultrasonic nebulizer (De Vilbiss 99; De Vilbiss, Heston, UK). The sputum sam- ples were kept at 4 Њ C for no longer than 2 h prior to processing. The volume of the sample was recorded and the sample was diluted with 2 ml of Hanks' balanced salt solution containing 1% dithiothreitol (Sigma Chemicals, Poole, UK). Total cell counts were done on a hemocytometer using Kimura stain, and slides were made with a cytospin (Shandon, Runcorn, UK) and stained with May-GrunwaldGiemsa stain for differential cell counts.
Pulmonary Function and Methacholine Provocation Test
Forced expiratory volume (FEV 1 ) was measured by a dry spirometer (Vitalograph, Buckingham, UK). Airway responsiveness was assessed by methacholine challenge. After an initial 0.9% NaCl inhalation patients were exposed to doubling concentrations of methacholine delivered as five breaths from a dosimeter (Dosimeter MB3; Mefar, Bovezzo, Italy) at 3-min intervals until FEV 1 fell by Ͼ 20% from the postsaline value. FEV 1 was measured 2 min after each inhalation. The concentration of histamine giving a 20% fall in FEV 1 (PC 20 ) was determined by linear interpolation from the log 10 concentration-response curve.
Statistical Analysis
Data are given as means Ϯ SEM. Comparisons of H 2 O 2 and NO concentrations between groups were made by Kruskal-Wallis test and 
RESULTS
Normal subjects had the lowest H 2 O 2 levels and it was below the limit of detection in 10 healthy subjects (Table 1) . In steroid-naive asthmatic patients, concentrations of exhaled H 2 O 2 and NO were significantly elevated, whereas those well-controlled on inhaled steroid treatment exhibited significantly lower levels of H 2 O 2 and NO in their exhaled air, which were similar to normal values. Unstable asthmatic patients had elevated H 2 O 2 levels in expired condensate, whereas their exhaled NO was similar to levels in normal subjects (Figure 2 ). There was a negative correlation between H 2 O 2 and PC 20 methacholine ( Figure 3A) , and positive correlation between eosinophil count in induced sputum and H 2 O 2 ( Figure 3B ) and NO levels ( Figure 3C ). However, there was no correlation between the concentrations of exhaled NO and PC 20 values in these patients. The relationship between H 2 O 2 , NO, and FEV 1 was assessed in all asthmatic subjects and no correlation was found.
DISCUSSION
We have found that levels of exhaled H 2 O 2 and NO were elevated in mild asthmatic patients compared with normal control subjects and were related to the eosinophil differential counts in induced sputum. Exhaled H 2 O 2 levels were also related to airway responsiveness. Expired H 2 O 2 and NO levels were normal in well-controlled asthma patients treated with inhaled corticosteroids, suggesting that these exhaled markers reflect airway inflammation in asthma. However, in unstable severe patients, the levels of exhaled H 2 O 2 were elevated, while exhaled NO levels were normal. The concentrations of exhaled H 2 O 2 measured in normal subjects were similar to those reported in previous studies (11, (13) (14) (15) . In asthmatic patients, the mean level of exhaled H 2 O 2 (0.72 M) is also comparable to levels obtained previously from stable asthmatic children (0.8 M) (14) . However, higher levels have been reported in patients with an exacerbation of asthma (1.5 M) (15) .
Increased oxidative stress is implicated in asthma (7) and this may be reflected by expired H 2 O 2 . An increased concentration of exhaled H 2 O 2 may represent an increased production of oxidants and/or a reduced free radical scavenging capacity in asthmatic airways. Oxygen radicals may contribute to epithelial shedding, release of inflammatory mediators, and development of airway hyperresponsiveness. Thus, a close relationship between O 2 и produced by circulating neutrophils and the degree of airway hyperresponsiveness has been shown in asthmatic patients (23) . Furthermore, peroxynitrite formed by a reaction between O 2 и and NO causes airway hyperresponsiveness in animals (24) . Indeed, we found a significant correlation between exhaled H 2 O 2 concentrations and the degree of airway hyperresponsiveness to methacholine in our patients.
Activation of inflammatory cells, and particularly eosinophils, is a key feature of asthmatic inflammation (4, 7) , and may be reflected by eosinophils in induced sputum (18, 25) . In the present study, we found a significant correlation between exhaled H 2 O 2 and NO and eosinophil counts in induced sputum. Because eosinophil differential counts in sputum have been shown to relate to the intensity of airway inflammation in asthma measured in bronchial biopsies and to the severity of the disease (25, 26) , this relationship supports the use of expired H 2 O 2 and NO in assessing airway inflammation in asthmatic patients. However, measurement of exhaled H 2 O 2 and NO may give different information about the inflammatory process. Although almost all of the steroid-naive asthmatic patients had elevated levels of exhaled NO, only approximately 70% of them had increased levels of exhaled H 2 O 2 , suggesting that in some patients there is no overproduction of oxidants. This finding implies that measurement of exhaled NO is a more sensitive technique in diagnosing asthma, but that not all of these patients have enhanced oxidative stress. Some of these patients did not need to use a bronchodilator for several months before the study, although they were diagnosed as asthmatic and had airway hyperresponsiveness. In patients well-controlled with inhaled steroids, both exhaled NO and H 2 O 2 showed a similar pattern. Corticosteroids inhibit the oxidative burst of leukocytes and also inhibit expression of inducible nitric oxide synthase resulting in a reduction of exhaled H 2 O 2 and NO. Steroid treatment also inhibits eosinophil recruitment to the airways, therefore it may influence exhaled mediator levels by preventing the influx of H 2 O 2 and NO producing cells. The differences in exhaled H 2 O 2 levels between the inhaled steroid-naive and the steroid-treated patients imply differences in oxidative stress between these two groups. However, in severe unstable asthmatics, exhaled H 2 O 2 levels were elevated, despite the use of high doses of inhaled and of oral steroids, whereas concentrations of exhaled NO were almost normal. Thus, the patients with severe asthma who are still symptomatic presumably have ongoing inflammation as reflected by sputum eosinophil despite steroid therapy, whereas exhaled NO is normalized since iNOS induction sensitive to steroids, while oxidative stress is still present because of the residual inflammation.
In summary, our study shows that the levels of exhaled H 2 O 2 and NO are elevated in asthmatic patients and this is related to other indices of airway inflammation. The fact that expired H 2 O 2 is elevated in patients with severe asthma not well controlled on high doses of inhaled steroids, whereas exhaled NO is normal, indicates that this measurement may be more useful in monitoring control of asthmatic inflammation.
